Echo Therapeutics (ECTE) Posts Q2 Loss of 51c/Share
Tweet Send to a Friend
Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.51), $0.30 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
